ticarcillin has been researched along with Community Acquired Infection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Sadikot, RT; Swenson, CE | 1 |
| Argaud, L; Illinger, J; Martin, O; Mohammedi, I; Robert, D; St Denis, M | 1 |
| Baughman, R; Boylen, CT; Chan, JC; Charan, NB; Cormier, YC; Erickson, A; Grossman, R; Kirmani, N; Shlaes, DM; Suh, B | 1 |
| Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV | 1 |
1 review(s) available for ticarcillin and Community Acquired Infection
| Article | Year |
|---|---|
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
2 trial(s) available for ticarcillin and Community Acquired Infection
| Article | Year |
|---|---|
Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam; Ticarcillin | 1994 |
[The clinical efficacy of ticarcillin/clavulanate in severe pneumonia].
Topics: Acute Disease; Adolescent; Adult; Clavulanic Acids; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Humans; Lung Abscess; Middle Aged; Pneumonia, Bacterial; Ticarcillin; Time Factors | 2000 |
3 other study(ies) available for ticarcillin and Community Acquired Infection
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
[Community-acquired Pseudomonas aeruginosa bacteremic pneumonia in a "healthy" subject].
Topics: Adult; Anti-Infective Agents; Bacteremia; Bronchoalveolar Lavage; Ciprofloxacin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Male; Penicillins; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 2003 |